GlobalIPNews

Sign Up
|
Login
|

03:41:00 Tue 24 Mar 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Shanghai Jiao Tong Univer

(49)

Tianjin University

(27)

Tianjin University of Sci

(6)

(5)

Hoffmann La Roche

(5)

Lunan Pharmaceutical Grou

(5)

Meilan Hangzhou Pharmaceu

(5)

(5)

Sanofi-Aventis Deutschlan

(5)

Tianjin University of Tec

(5)

Beijing Rongai Medical Bi

(4)

Chengdu Chipscreen Pharma

(4)

Guangdong HEC Pharmaceuti

(4)

Hunan University of Chine

(4)

Institute of Materia Medi

(4)

Jiangsu Hengrui Medicine;

(4)

Ningxia Medical Universit

(4)

Ruijin Hospital Shanghai

(4)

(4)

Shanghai Inst Of Pharmace

(4)

Wuhan Abclonal Co Ltd

(4)

Zhangzhou Pien Tze Huang

(4)

Zhongke Zhongshan Pharmac

(4)

(3)

(3)

Fudan University

(3)

Genzyme Corporation

(3)

Guangdong Hospital of Tra

(3)

Institute Military Medici

(3)

Nanjing Huawei Medical Eq

(3)

Nanjing Kang Chuan Ji Pha

(3)

PLA Air Force Medical Uni

(3)

Shandong Xinhua Pharmaceu

(3)

Shandong Yirentang Pharma

(3)

Shanghai Allist Pharmaceu

(3)

Shenzhen Salubris Pharmac

(3)

Sichuan University

(3)

Southern Medical Universi

(3)

Union Hospital, Tongji Me

(3)

West China Hospital, Sich

(3)

Anhui Guixin Linyan Pharm

(2)

(2)

Apex Biosciences Pte Ltd

(2)

Beijing Innote Biotechnol

(2)

Beijing Lande Wanbang Pha

(2)

Beijing Subenyuanhe Biote

(2)

Beijing Tongrentang Healt

(2)

Beijing Youcare Kechuang

(2)

(2)

Biostime Guangzhou Health

(2)

Blueprint Medicines

(2)

CETC Zhiwei Shanghai Tech

(2)

Cangzhou Bencao Yuchong T

(2)

Canopy Immuno Therapeutic

(2)

Chengdu First Pharmacedti

(2)

Chengdu Qingshan Likang P

(2)

Chengdu Sibeibo Pharmaceu

(2)

Chengdu University of Tra

(2)

China Japan Friendship Ho

(2)

China Pharmaceutical Univ

(2)

Chongqing Boji Pharmaceut

(2)

Chongqing Pujian Pharmace

(2)

Chongqing Traditional Chi

(2)

Chongqing University Canc

(2)

Council of Scient & Indus

(2)

Dalian University of Tech

(2)

Entos Pharmaceuticals U K

(2)

F Hoffmann La Roche Ag [c

(2)

Fujian University of Trad

(2)

Gan & Lee Pharmaceuticals

(2)

Ganjiang Traditional Chin

(2)

Guangdong Muhou Pharmaceu

(2)

Guangdong Pharmaceutical

(2)

Guangdong Power Grid; Ele

(2)

Guangji Pharmaceutical Ji

(2)

Guangxi Inst Chinese Medi

(2)

Guangzhou Hanguang Pharma

(2)

Haisco Pharmaceutical Gro

(2)

Hangzhou First People\'s

(2)

Hangzhou Hospital of Trad

(2)

Hangzhou New Element Phar

(2)

Hebei Chemical & Pharmace

(2)

Hebei Hejia Pharmatech Gr

(2)

Hebei University of Scien

(2)

Henan Agricultural Univer

(2)

Henan University of Techn

(2)

Hubei Shuangxing Pharmace

(2)

Hunan Fuxing Feige Pharma

(2)

Hunan Jiudian Hongyang Ph

(2)

Hunan Wugan Pharmaceutica

(2)

Incarda Therapeutics Inc

(2)

Institute of Chinese Mate

(2)

Jiangsu Allist Biological

(2)

Jiangsu Jinglixin Pharmac

(2)

Jiangsu Kanion Pharmaceut

(2)

Jiangsu Lianhuan Pharmace

(2)

Jiangsu Ocean University

(2)

Jiangsu Skyrun Pharmaceut

(2)

Jiangsu Yabang Aipusen Ph

(2)

Jiangsu Yueshi Pharmaceut

(2)

Jinhua Municipal Central

(2)

Kaiyuan Pharmaceutical An

(2)

Kangbaida Sichuan Biomedi

(2)

Lanzhou University

(2)

Lysia Therapeutics Inc

(2)

Miaowang Pharmaceutical G

(2)

Mrx Medical Ltd

(2)

Nanjing Chia-Tai Tianqing

(2)

Nanjing Yewin Pharmacenti

(2)

Ningbo Ziyuan Pharmaceuti

(2)

Northeastern University;

(2)

Northwest A&f Univ Shenzh

(2)

(2)

Renji Hospital Shanghai J

(2)

SZYY Group Pharmaceutical

(2)

Shaanxi Huayuan Zhenghe P

(2)

Shaanxi Zhonghongkerui In

(2)

Shandong New Time Pharmac

(2)

Shanghai Advanced Clinica

(2)

Shanghai Henlius Biotech

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Qilu Pharmaceuti

(2)

Shanghai Qilu Pharmaceuti

(2)

Shanghai Ruitinuo Pharmac

(2)

Shenyang Pharmaceutical U

(2)

Shijiazhuang Zangnuo Phar

(2)

Shuangyi Original Shangha

(2)

Sichuan Credit Pharmaceut

(2)

State Grid Jibei Electric

(2)

Taizhou Mabtech Pharmaceu

(2)

Tencent Tech Shanghai Co

(2)

Teven Therapeutics Pty Lt

(2)

The University of North C

(2)

Tianjin University of Com

(2)

Tibetan Hospital of Qingh

(2)

Tongji Medical College Ho

(2)

University of Science and

(2)

Wuxue Hongyuan Pharmaceut

(2)

Xian New Hope Medical Dev

(2)

Xinhua Hospital affiliate

(2)

Xinxiang Medical Universi

(2)

Yangtze River Delta Medic

(2)

Yunji Xinguang Zhuhai Mic

(2)

(2)

Zhejiang Cuize Pharmaceut

(2)

11949098 Canada Inc

(1)

4teen4 Pharmaceuticals Gm

(1)

ADARx Pharmaceuticals

(1)

Abbisko Therapeutics

(1)

Abionix Pharmaceuticals I

(1)

Ablynx Nv [be]; Sanofi

(1)

(1)

Ac Pharmaceuticals Co Ltd

(1)

Acad Ziekenhuis Leiden H

(1)

(1)

Acerta Pharmaceuticals In

(1)

Aconcagua Bio Inc [us]; G

(1)

Act225 Biotherapeutics Co

(1)

(1)

(1)

Administracion General De

(1)

Affiliated Hospital Of Ch

(1)

Affiliated Hospital of Gu

(1)

Affiliated Hospital of Ji

(1)

Affiliated Hospital of Qi

(1)

Affiliated Hospital of Sh

(1)

Agency for Science, Techn

(1)

Agrichina Pharmaceutical

(1)

Aiqiji Creation

(1)

Aisi Tuokang Biological M

(1)

Aite Shenbo Suzhou Pharma

(1)

Aiyi Life Tech Guangdong

(1)

Akeso Biopharma Co Ltd

(1)

Albert Ludwig University

(1)

(1)

Alia Therapeutics Ltd

(1)

Alipay Hangzhou Technolog

(1)

Allife Medicine (Beijing)

(1)

Alpha Pharmaceutical Co L

(1)

Alphinity Usa Inc

(1)

(1)

Anderson Asher Wu [us]; B

(1)

Anhui Bensentang Biologic

(1)

Anhui Conch Material Scie

(1)

Anhui Duan Pharmaceutical

(1)

Anhui Funland Biological

(1)

Anhui Hefu Pharmaceutical

(1)

Anhui Huajun Pharmaceutic

(1)

Anhui Jinhe Industrial

(1)

Anhui Yuanjing Pharmaceut

(1)

Anhui Zhifei Longcom Biop

(1)

(1)

Aonuo China Pharmaceutica

(1)

Aptose Biosciences Inc; H

(1)

Argus Hunan Biopharmaceut

(1)

Asahi Kasei Pharma Corp [

(1)

Ascendis Pharma Oncology

(1)

Ascentage Pharma Suzhou C

(1)

Ascentawits Pharmaceutica

(1)

(1)

AstraZeneca Sweden AB

(1)

Astrazeneca Uk Ltd [gb];

(1)

Atossa Therapeutics

(1)

Aurisco Pharmaceutical Ti

(1)

Avant Meats Company Ltd

(1)

Baifang Yingku Pharmaceut

(1)

Baowu Special Metallurgy;

(1)

Bd Switzerland Sarl

(1)

Beijing Bioneovan Co Ltd

(1)

Beijing Danqing Medicine

(1)

Beijing Donghuayuan Medic

(1)

Beijing Fuyuan Pharmaceut

(1)

Beijing Giluntide Pharmac

(1)

Beijing Inst Of Heart Lun

(1)

Beijing Joinn Biotechnolo

(1)

Beijing Kangyi Pharmaceut

(1)

Beijing Konruns Pharmaceu

(1)

Beijing Meiao Century Med

(1)

Beijing Nova Pharmaceutic

(1)

Beijing Oriental Fortune

(1)

Beijing Puqi Pharmaceutic

(1)

Beijing Renwei Pharmaceut

(1)

Beijing Ribocure Pharmace

(1)

Beijing Saite Mingqiang P

(1)

Beijing Silian Pharmaceut

(1)

Beijing Taiyang Pharmaceu

(1)

Beijing Tong Ren Tang Gro

(1)

Beijing University of Chi

(1)

Beijing University of Chi

(1)

Beijing Winsunny Pharmace

(1)

Beijing Xinchuang Biologi

(1)

Beijing Xuanjingrui Pharm

(1)

Beijing Youan Hospital, C

(1)

Beijing Yuanfang Tongda P

(1)

Bide Pharmatech Co Ltd

(1)

Big Health Res Institute

(1)

Bijie Hospital Of Zhejian

(1)

Binzhou Medical College

(1)

(1)

Biocytogen Pharmaceutical

(1)

Biodlink Biopharm Co Ltd

(1)

Biology Inst Hebei Academ

(1)

Biophore India Pharmaceut

(1)

Bliss Biopharmaceutical,

(1)

BlossomHill Therapeutics

(1)

Boehringer Ingelheim Inte

(1)

Bristol Myers Squibb

(1)

Bugworks Res Inc

(1)

CSPC Innovation Pharmaceu

(1)

CSPC Zhongqi Pharmaceutic

(1)

(1)

Capital Medical Universit

(1)

Capital University of Med

(1)

Carnegie Mellon Univ [us]

(1)

Central South University

(1)

Cf Pharmatech Inc

(1)

Changchun GeneScience Pha

(1)

Changchun University of C

(1)

Changchunteng Biological

(1)

Changsha Hongan Jiyuan Bi

(1)

Changzhou Sunlight Pharm

(1)

Changzhou Yabang Pharmace

(1)

Chemical Research Institu

(1)

Chengdu Anlite Pharmaceut

(1)

Chengdu Bailiduote Biolog

(1)

Chengdu Brilliant Pharmac

(1)

Chengdu Chuanda Jinzhong

(1)

Chengdu Cynogen Bio Pharm

(1)

Chengdu Jingshi Pharmaceu

(1)

Chengdu Kanghong Pharmace

(1)

Chengdu Puth Pharmaceutic

(1)

Chengdu Runxintang Pharma

(1)

Chengdu Saijing Biopharma

(1)

Chengdu Scimount Pharmate

(1)

Chengdu Xingwang Animal P

(1)

Chengdu Yanmei Innovation

(1)

Chenguang Biotech Group

(1)

Chia Tai Tianqing Pharmac

(1)

Children\'s Hospital of C

(1)

China Acad Of Chinese Med

(1)

China Academy of Chinese

(1)

China Inst Of Sport Medic

(1)

China Inst Veterinary Dru

(1)

China Oilfield Services;

(1)

China Pharmaceutical Univ

(1)

China Salt Jintan; Tianji

(1)

China University of Geosc

(1)

Chinese University of Hon

(1)

Chongqing Carelife Pharma

(1)

Chongqing Hilan Pharmaceu

(1)

Chongqing Hongsheng Pharm

(1)

Chongqing Jingbei Tech Co

(1)

Chongqing Medical Univers

(1)

Chongqing Sanlitang Chine

(1)

Chongqing University

(1)

Chongqing University; Cho

(1)

Chongqingg Tiandi Pharmac

(1)

Cismic Therapeutics Inc

(1)

(1)

Click Therapeutics

(1)

Convalife Shanghai Co Ltd

(1)

Corden Pharma Int Gmbh

(1)

Cornell Univ [us]; Sander

(1)

(1)

Crucial Pure Environmenta

(1)

Cxs Therapeutics

(1)

(1)

Cytotech Biopharma Inc

(1)

Daegu Gyeongbuk Institute

(1)

Dalian Minzu Univ

(1)

Dalian University

(1)

Dalian University of Tech

(1)

Dana Farber Cancer Inst I

(1)

Dongguan Bosheng Biologic

(1)

Dukhovlinov Ilia Vladimir

(1)

(1)

East China Branch of Stat

(1)

East China University of

(1)

East China University of

(1)

Ecole Polytechnique Féd�

(1)

Elanco Us Inc [us]; Elanc

(1)

Eli Lilly and Company

(1)

Elite Pharmaceutical Solu

(1)

Embold Therapeutics Inc

(1)

Enveric Biosciences Canad

(1)

European Pharma Group B V

(1)

Everads Therapy Ltd

(1)

Evox Therapeutics Ltd

(1)

Ewha University Industry

(1)

F Hoffmann La Roche Ag [c

(1)

Feilong Health (Shenyang)

(1)

Ferring Int Center S A

(1)

Finn Therapeutics Ltd

(1)

First Affiliated Hospital

(1)

First Affiliated Hospital

(1)

First People\'s Hospital

(1)

First People\'s Hospital

(1)

First Teaching Hospital,

(1)

Fitabeo Therapeutics Ltd

(1)

Foghorn Therapeutics

(1)

Foundation For Biomedical

(1)

Fujian Jiankangzhilu Heal

(1)

Fujian Jushen Pharmaceuti

(1)

Fujian Medical University

(1)

Fujian South Pharmaceutic

(1)

(1)

Fuzhou University

(1)

Gan & Lee Pharmaceutic

(1)

Gangkang Pharmaceutical C

(1)

Gannan Innovation And Tra

(1)

Gansu Jubaicao Pharmaceut

(1)

Gansu University of Chine

(1)

Gansu Zhizi Pharmaceutica

(1)

(1)

Gencc Gmbh & Co Kg

(1)

Genentech Inc [us]; Roche

(1)

Gilead Sciences

(1)

Gilgames Pharma Inc

(1)

GlaxoSmithKline Intellect

(1)

Glaxosmithkline Intellect

(1)

Glaxosmithkline Intellect

(1)

Glaxosmithkline Ip No 2 L

(1)

Glaxosmithkline Llc

(1)

Glenmark Speciality S A

(1)

Global Energy Interconnec

(1)

Golden Mab Co Ltd

(1)

Graviton Bioscience Bv

(1)

Grifols Worldwide Operati

(1)

GuangXi University

(1)

Guangdong China Resources

(1)

Guangdong Danlan Int Biot

(1)

Guangdong Hongshanhu Phar

(1)

Guangdong Jiachuang Pharm

(1)

Guangdong Juhai Tech Co L

(1)

Guangdong Lecaoyuan Healt

(1)

Guangdong Liancun Pharmac

(1)

Guangdong Longfu Pharmace

(1)

Guangdong Nanguo Pharmace

(1)

Guangdong Pharmaceutical

(1)

Guangdong Runkang Pharmac

(1)

Guangdong Weizheng Pharma

(1)

Guangshengtang Zhongxing

(1)

Guangxi Institute of Bota

(1)

Guangxi Jiannong Medical

(1)

Guangxi Strong Life Pharm

(1)

Guangxi Therapeutic Medic

(1)

Guangxi University of Chi

(1)

Guangzhou Chaoliliang Bio

(1)

Guangzhou Chuangrui Healt

(1)

Guangzhou Fenzi Informati

(1)

Guangzhou Yuanbo Pharmace

(1)

Guangzhou Zhengda Medical

(1)

Guarnieri Michael

(1)

Guhan Traditional Chinese

(1)

Guizhou University of Tra

(1)

Guoke Guangzhou Cell Tech

(1)

Guoyaojituan Tongjitang G

(1)

Haikou Peoples Hospital C

(1)

Hainan Jinrui Pharmaceuti

(1)

Hainan Medical Univ Haina

(1)

Hainan University

(1)

(1)

Hanghzou Bio Sincerity Ph

(1)

Hangzhou Advanced Researc

(1)

Hangzhou Borui Simo Biome

(1)

Hangzhou City Xiaoshan Di

(1)

Hangzhou Dianzi Universit

(1)

Hangzhou Gongshu Bianyuan

(1)

Hangzhou Huaan Biotechnol

(1)

Hangzhou Jiechuangrui Med

(1)

Hangzhou Medical College

(1)

Hangzhou Normal Universit

(1)

Hangzhou Qunan Likang Bio

(1)

Hangzhou Shengyu Biomedic

(1)

Hangzhou Third Peoples Ho

(1)

Hangzhou Zhongmei Huadong

(1)

Hangzhou Zhongmei Huadong

(1)

Hanzhong Vocational and T

(1)

Harbin Commercial Univers

(1)

Harbin Institute of Techn

(1)

Harbin Xiashi Orthopedics

(1)

Harbin Yuyantang Traditio

(1)

Hbm Alpha Pharma As

(1)

Healthy Yuanhaibin Pharma

(1)

Hebei Honz Pharmaceutical

(1)

Hebei Jingyi Caomu Tech C

(1)

Hebei Kainuo Pharmaceutic

(1)

Hebei Normal University S

(1)

Hebei Renhe Yikang Pharma

(1)

Hebei Sanxin Pharmaceutic

(1)

Hefei Huafang Pharmaceuti

(1)

Hefei University of Techn

(1)

Hefei Yunzhen Information

(1)

Heilongjiang University o

(1)

Helmholtz Zentrum Muenche

(1)

(1)

Henan Cancer Hospital

(1)

Henan Childrens Hospital

(1)

Henan Jinbaihe Biotechnol

(1)

Henan Radiomedical Pharma

(1)

Henan Ruideli Forage Co L

(1)

Henan Tiefu Medical Tech

(1)

Henan University

(1)

Henan University of Chine

(1)

(1)

Hoffmann-La Roche

(1)

Hohhot Shouchuang Chunhua

(1)

Hongxing Xianghe Taicang

(1)

Huana Global Biotech Co L

(1)

Huanggang Humanwell Pharm

(1)

Huangshi Huli Environment

(1)

Huaren Medical Res Anhui

(1)

Hubei Bio Pharmaceutical

(1)

Hubei Gongtong Zaiti Phar

(1)

Hubei Hongyuan Pharmaceut

(1)

Hubei University of Medic

(1)

Hubei Zaofu Pharmaceutica

(1)

Huhhot First Hospital

(1)

Huida Shanghai Biotechnol

(1)

Huihe Biotechnology Shang

(1)

Huizhou Jiuhui Pharmaceut

(1)

Huizhou Zhongli Pharmaceu

(1)

Hunan Academy of Chinese

(1)

Hunan Asidikang Pharmaceu

(1)

Hunan Hanfang Kangyang Ph

(1)

Hunan Huize Bio Pharmaceu

(1)

Hunan Jingcheng Pharmaceu

(1)

Hunan Kelun Pharmaceutica

(1)

Hunan Norchem Pharmaceuti

(1)

Hunan Provincial Center F

(1)

Hunan Shengye Geotechnica

(1)

Hunan Xiangya Boai Rehabi

(1)

Hunan Yirentang Tradition

(1)

Hunan Zhuangyuan Pharmace

(1)

Huonslab Co Ltd

(1)

Hybio Pharmaceutical Co L

(1)

Hyundai Pharm Co Ltd

(1)

Ibsa Inst Biochimique Sa

(1)

Icon Therapeutics Inc

(1)

(1)

Industry Univ Cooperation

(1)

Inner Mongolia Changsheng

(1)

Inner Mongolia Changsheng

(1)

Inner Mongolia Research I

(1)

Inner Mongolia Research I

(1)

Inner Mongolia University

(1)

Innovent Biologics Inc

(1)

Innovstone Therapeutics

(1)

Inst Curie; Inst Nat Sant

(1)

Inst For Viral Disease Co

(1)

Inst Med Biotechnology Ca

(1)

Inst Of Materia Medica Ch

(1)

Inst Of Materia Medica Ch

(1)

Inst Of Military Veterina

(1)

Inst Regional Cancer Mont

(1)

Institut National De La S

(1)

Institut National De La S

(1)

Institute Of Science And

(1)

Institute Special Animal

(1)

Institute of Applied Ecol

(1)

Institute of Chinese Mate

(1)

Integro Theranostics Llc

(1)

(1)

Intrepid Labs Inc

(1)

Italfarmaco S P A

(1)

Janssen Pharmaceutica

(1)

Janssen Vaccines & Preven

(1)

Jazz Pharmaceuticals Irel

(1)

Jazz Pharmaceuticals Rese

(1)

Je Il Pharmaceutical Co L

(1)

Jenkem Technology Tianjin

(1)

Jewim Pharmaceutical Shan

(1)

Ji Can Artificial Intelli

(1)

Ji Hua Laboratory

(1)

Jiamusi University

(1)

Jiangnan Shipyard Group;

(1)

Jiangnan University

(1)

Jiangsu Alphamab Biopharm

(1)

Jiangsu Fangsheng Pharmac

(1)

Jiangsu Farver Pharma Co

(1)

Jiangsu Food & Pharmaceut

(1)

Jiangsu Haici Biological

(1)

Jiangsu Hansoh Pharmaceut

(1)

Jiangsu Henghai Medical S

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Hi Stone Pharmace

(1)

Jiangsu Huagang Pharmaceu

(1)

Jiangsu Institute of Poul

(1)

Jiangsu Jiaerke Pharmaceu

(1)

Jiangsu Kangbaide Pharmac

(1)

Jiangsu Nuohe Bituo New D

(1)

Jiangsu Nuotai Allsino Bi

(1)

Jiangsu Qianren Biotechno

(1)

Jiangsu Shangjiao Carbon

(1)

Jiangsu Sino Biopharma Co

(1)

Jiangsu University of Sci

(1)

Jiangsu Vocational Colleg

(1)

Jiangsu Wahoo Pharma Co L

(1)

Jiangsu Xietong Pharmaceu

(1)

Jiangsu Xingzongheng Biot

(1)

Jiangsu Yuyue Medical Equ

(1)

Jiangxi Brother Pharmaceu

(1)

Jiangxi Health Pharmaceut

(1)

Jiangxi Heying Pharmaceut

(1)

Jiangxi Hongxing Pharmace

(1)

Jiangxi Nabo Wine Co Ltd;

(1)

Jiangxi Yizhentang Tradit

(1)

Jiangzhong Pharmaceutical

(1)

Jilin Boda Pharmaceutical

(1)

Jilin Huirong Biotechnolo

(1)

Jilin Institute Of Pharma

(1)

Jilin Sihuan Aokang Pharm

(1)

Jilin University

(1)

Jiming Pharmatech Suzhou

(1)

Jinan Pengzheng Pharmaceu

(1)

Jinan University

(1)

Jinan University; Kaiping

(1)

Jingfang Tanyuan Guangzho

(1)

Jinggangshan University

(1)

Jining Shengtai Pharmaceu

(1)

Jinke Tianjin New Materia

(1)

Jisikai Suzhou Pharmaceut

(1)

Jiuzhou Hehui Changzhou P

(1)

Joint Stock Company BIOCA

(1)

Joonghun Pharmaceutical C

(1)

Jw Therapeutics R & D Sha

(1)

(1)

Kaimeike Shanghai Pharmac

(1)

Kaiping Genuine Biochemic

(1)

Kangjian Information Tech

(1)

Kanglong Huacheng Ningbo

(1)

Kangmei Pharmaceutical

(1)

Kaqiu Jiangsu Biotechnolo

(1)

(1)

Keyimei (Guangzhou) Healt

(1)

King\'s College London

(1)

Kk Yakult Honsha

(1)

(1)

Korea Medical Health Care

(1)

Kpc Pharmaceuticals Inc;

(1)

Kumoh National Institute

(1)

Kunming Institute of Bota

(1)

Kunming Institute of Zool

(1)

Kunming University

(1)

Kunshan Jingwei New Mater

(1)

(1)

L Perrigo Company

(1)

Lamina Pharmaceuticals In

(1)

Lanling Inspection And Te

(1)

Lanzhou Institute Husband

(1)

Lanzhou Institute of Chem

(1)

Lanzhou University Second

(1)

Laurus Labs Ltd

(1)

Leal Therapeutics Inc

(1)

Lee Geon Moo [kr]; Lee In

(1)

Leiyunshang Pharmaceutica

(1)

(1)

(1)

(1)

(1)

Lianyungang Guanxin Pharm

(1)

Liaoning Beihe Medical La

(1)

Liaoning Taiyang Pharmace

(1)

Liaoning Vocational Colle

(1)

Lindera Therapeutics Inc

(1)

Lingang Nat Laboratory

(1)

Lingtai Biological Medici

(1)

Lishui City People\'s Hos

(1)

Livzon Group Limin Pharma

(1)

Longhua Hospital Affiliat

(1)

Lu Pengcheng; Zunyi Medic

(1)

(1)

Lunan New Time Bio Tech C

(1)

Luoyang Polytechnic; Luoy

(1)

Luoyang Yanai Pharmaceuti

(1)

Luxembourg Inst Of Health

(1)

Maanshan Nuoente Pharmace

(1)

(1)

Maria Clementine Martin K

(1)

Medicine Park Co Ltd

(1)

Medilink Therapeutics, Su

(1)

Medisca Pharmaceutique

(1)

Meizhou People\'s Hospita

(1)

(1)

Metacen Therapeutics Inc

(1)

Metafora Biosystems [fr];

(1)

Mezzion Pharma Co Ltd [kr

(1)

Mindrank Ai Ltd

(1)

Mingguang Hospital Of Tcm

(1)

Mirati Therapeutics

(1)

(1)

Modern Chinese Medicine H

(1)

(1)

Mofu Purification Tech Be

(1)

Monolithic Cell Therapeut

(1)

Naiji Pharmaceutical Tech

(1)

Nain Biotech Hangzhou Co

(1)

Najiesi Wuhan Biomedical

(1)

Nanfang Hospital, Souther

(1)

Nanjing Gentai Pharmaceut

(1)

Nanjing Getein Biomedical

(1)

Nanjing Jisheng Aoma Biol

(1)

Nanjing Keenlisi Bio Medi

(1)

Nanjing Leading Medical T

(1)

Nanjing Licheng Pharmaceu

(1)

Nanjing Lingnuo Biomedica

(1)

Nanjing Normal Univ Taizh

(1)

Nanjing Qiji Biotechnolog

(1)

Nanjing Ruijie Pharma Co

(1)

Nanjing Sanhome Pharmaceu

(1)

Nanjing University of Chi

(1)

Nanjing Wangzhixing Pharm

(1)

Nankai University

(1)

Nanning Normal University

(1)

Nantong Han Di Automation

(1)

Nantong Sanyue Traditiona

(1)

Nantong Senxuan Pharmaceu

(1)

Nantong Xinde Pharmaceuti

(1)

Nat Cancer Center [kr]; N

(1)

Nat Institute For Communi

(1)

Navigo Proteins

(1)

Neurotech International L

(1)

Ningbo Combireg Pharmaceu

(1)

Ningbo No 2 Hospital

(1)

Ningde Contemporary Amper

(1)

Nitanya Beijing Health Te

(1)

Nkd Pharma Co Ltd

(1)

North Sichuan Medical Col

(1)

Northwestern Polytechnica

(1)

Northwestern University

(1)

Novabiotics Ltd

(1)

Novartis; Gilead Sciences

(1)

OMRON Tateisi Electronics

(1)

Oblita Therapeutics Bvba

(1)

Ocean University China

(1)

Olix Pharmaceuticals Inc

(1)

Orbilan Pharma Ltd

(1)

Osstem Pharma Co Ltd

(1)

Ot Pharmaceuticals Ab

(1)

Otsuka Pharmaceutical

(1)

(1)

Oxybio Ltd; Chicago An &

(1)

Panan County Chinese Medi

(1)

Panjin Industrial Technol

(1)

Peg Bio Biopharm Co Ltd C

(1)

Peking University First H

(1)

Peking University First H

(1)

Peking University School

(1)

Peking University Third H

(1)

(1)

(1)

Pharmacosmos Ltd

(1)

Pharmaengine Inc

(1)

(1)

(1)

Pinxihui Xiamen Biologica

(1)

Polypeptide Therapeutic S

(1)

Poonglim Pharmatech Inc

(1)

Poseida Therapeutics

(1)

Powerchina Municipal Cons

(1)

Prec Brain Science Biotec

(1)

President and Fellows of

(1)

Progentos Therapeutics In

(1)

Provectus Pharmatech Inc

(1)

Ptc Therapeutics Hd Inc

(1)

Pyros Pharmaceuticals Inc

(1)

Qilu Hospital of Shandong

(1)

Qilu Pharmaceutical

(1)

Qilu Pharmaceutical Inner

(1)

Qingdao Central Hospital

(1)

Qingdao Eastsea Pharmaceu

(1)

Qingdao Gon Science & Tec

(1)

Qingdao Hengxing Universi

(1)

Qingdao Huashang Xinyao P

(1)

Qingdao Municipal Hospita

(1)

Qingdao Yanding Cell Biot

(1)

Qinghai Pharmaceutical Co

(1)

Qitaihe Kangcaotang Piece

(1)

Quirsphere Biotherapeutic

(1)

Ranok Therapeutics Hangzh

(1)

Re3b Therapeutics Ug I G

(1)

Regeneron Pharmaceuticals

(1)

Regulus Therapeutics

(1)

Research Institute Of Yib

(1)

Research Triangle Institu

(1)

Resq Pharma Inc [us]; The

(1)

Revio Therapeutics Llp

(1)

Reyoung Pharmaceutical

(1)

RiboX Therapeutics

(1)

Rigerna Therapeutics Beij

(1)

Ruddy Marcella [us]; Rege

(1)

Ruijin Hospital Shanghai

(1)

Ruilai Pharmaceutical Tec

(1)

(1)

(1)

Sahin Fikrettin

(1)

Saikesaisi Biotechnology

(1)

Saitama Medical Universit

(1)

Sanofi Aventis; Eli Lilly

(1)

Sanofi Sa [fr]; Inst Nat

(1)

(1)

Scinopharm Changshu Pharm

(1)

Sdic Ronghe Hangzhou Tech

(1)

Seqirus Pty Ltd [au]; Seq

(1)

Seradialogistics [de]; Ge

(1)

Shaanxi Jiuzhou Pharmaceu

(1)

Shaanxi Kanghe Li Feng Bi

(1)

Shaanxi Kangnaduo Pharmac

(1)

Shaanxi Traditional Chine

(1)

Shaanxi University of Chi

(1)

Shandong Boyuan Pharmaceu

(1)

Shandong Chuangxin Pharma

(1)

Shandong First Medical Un

(1)

Shandong First Medical Un

(1)

Shandong Guangming Pharma

(1)

Shandong Heqi Pharmaceuti

(1)

Shandong Holly Pharmaceut

(1)

Shandong Huashi Pharmaceu

(1)

Shandong Institute of Med

(1)

Shandong Jianxintang Trad

(1)

Shandong Jiumu Feed Co Lt

(1)

Shandong Jths New Materia

(1)

Shandong Lukang Pharmaceu

(1)

Shandong Luoxin Lekang Ph

(1)

Shandong Luoxin Pharmaceu

(1)

Shandong Maternal And Chi

(1)

Shandong Meimao Pharmaceu

(1)

Shandong Shinva Medical I

(1)

Shandong University of Tr

(1)

Shandong University; Shan

(1)

Shandong Weikang Biologic

(1)

Shandong Xier Kangtai Pha

(1)

Shandong Yuze Yinfeng Ani

(1)

Shandong Zhongbaokang Med

(1)

Shandong Zhongtai Pharmac

(1)

Shangdong Luoxin Pharmace

(1)

Shanghai 9th People\'s Ho

(1)

Shanghai 9th People\'s Ho

(1)

Shanghai Argo Biopharmace

(1)

Shanghai Bocimed Pharmace

(1)

Shanghai Chengfan Pharmac

(1)

Shanghai Ennovabio Pharma

(1)

Shanghai First Maternity

(1)

Shanghai Fosun Pharmaceut

(1)

Shanghai Fosun Xingtai Ph

(1)

Shanghai Guangsheng Pharm

(1)

Shanghai Haini Pharmaceut

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Huantong Busines

(1)

Shanghai Huiji Pharmaceut

(1)

Shanghai Inst Of Immune A

(1)

Shanghai Inst Of Immune A

(1)

Shanghai Institute of Bio

(1)

Shanghai Institute of Mat

(1)

Shanghai Institute of Mat

(1)

Shanghai Institute of Mat

(1)

Shanghai Institute of Mic

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Kaibao Pharmaceu

(1)

Shanghai Lee Bio Pharmace

(1)

Shanghai Lixin Lianchuang

(1)

Shanghai Maikunte Pharmac

(1)

Shanghai Mengke Pharmaceu

(1)

Shanghai Modern Hasen Sha

(1)

Shanghai Modern Pharmaceu

(1)

Shanghai New Asiatic Phar

(1)

Shanghai Nuozhi Weizhen P

(1)

Shanghai Pharmaceutical H

(1)

Shanghai Pulmonary Hospit

(1)

Shanghai Ringene Biopharm

(1)

Shanghai Scond Pharmaceut

(1)

Shanghai Shiling Pharmace

(1)

Shanghai Tianyanchen New

(1)

Shanghai University Of En

(1)

Shanghai University of Tr

(1)

Shanghai University of Tr

(1)

Shanghai Xinfeng Health T

(1)

Shanghai Xingzhilin Medic

(1)

Shanghai Xudong Haipu Jia

(1)

Shanghai Yizhong Pharmace

(1)

Shanghai Yuli Biotechnolo

(1)

Shanghai Yunsheng Yanxin

(1)

Shanghai Zedeman Medical

(1)

Shanghai Zhonglv New Ener

(1)

Shangrao Shajon High Tech

(1)

Shanxi Jinshuiyuan Biolog

(1)

Shanxi Medical University

(1)

Shanxi Shuangyan Pharmace

(1)

Shanxi Siwei Intelligent

(1)

Shanxi Traditional Chines

(1)

Shen Zhen Long Life Biolo

(1)

Shenji Changhua Beijing B

(1)

Shennong Zhisuan Beijing

(1)

Shenyang Pharmaceutical U

(1)

Shenzhen Dieckmann Biolog

(1)

Shenzhen Ftd Packaging Pr

(1)

Shenzhen Integrated Tradi

(1)

Shenzhen Jiete Automation

(1)

Shenzhen Kangning Hospita

(1)

Shenzhen Kangzheweisheng

(1)

Shenzhen Liguo Medicament

(1)

Shenzhen Nanshan Distr Pe

(1)

Shenzhen Newdel Biotech

(1)

Shenzhen Optimum Biologic

(1)

Shenzhen Porshealth Bioen

(1)

Shenzhen Shenchuang Biolo

(1)

Shenzhen Shenrunxi Biotec

(1)

Shenzhen Yuanbang Pharmac

(1)

Shijiazhuang Disikaiwei P

(1)

Shijiazhuang No 4 Pharmac

(1)

Shijiazhuang Shimu Pharma

(1)

Shijiazhuang University

(1)

Shimadzu Corp [jp]; Nat I

(1)

Shiseido; Zhejiang Univer

(1)

Shouyao Holdings Beijing

(1)

Shujing Biopharma Co Ltd

(1)

Sichuan Aobang Gude Pharm

(1)

Sichuan Chonggu Tech Co L

(1)

Sichuan Huiyu Pharmaceuti

(1)

Sichuan Jinlin Pharmaceut

(1)

Sichuan Kelun Pharmaceuti

(1)

Sichuan Kelun-Biotech Bio

(1)

Sichuan Konkasnow New Mat

(1)

Sichuan Neo Green Pharmac

(1)

Sichuan Provincial People

(1)

Sichuan Pukang Pharmaceut

(1)

Sichuan Shennong Pharmace

(1)

Sichuan Xindi Biopharmace

(1)

Signalrx Pharmaceuticals

(1)

Sinograin Zhenjiang Quali

(1)

Sinopharm Zhijun Shenzhen

(1)

Sinopharm Zhijun Shenzhen

(1)

Sinovac Res & Development

(1)

(1)

Softkemo Pharma Corp

(1)

Soochow University

(1)

South Central University

(1)

South West University

(1)

Sph No 1 Biochemical & Ph

(1)

Spirit Jinyu Biological P

(1)

Standard Medicine Standar

(1)

State Grid Shanghai Munic

(1)

Storm Therapeutics

(1)

Suifenhe Yongsheng Enterp

(1)

Supermus Pharmaceuticals

(1)

Suzhou Aitesen Pharmaceut

(1)

Suzhou Boao Mingsai Biolo

(1)

Suzhou Bokang Pharmaceuti

(1)

Suzhou Boyan Pharmaceutic

(1)

Suzhou Caibo Medical Labo

(1)

Suzhou Haibo Saisi Biotec

(1)

Suzhou Haishun Packaging

(1)

Suzhou Medinoah Co Ltd; S

(1)

Suzhou No 4 Pharmaceutica

(1)

Suzhou Oukang Weishi Biot

(1)

Suzhou Puhe Pharmaceutica

(1)

Suzhou Sanjun Pharmaceuti

(1)

Suzhou Spring Sea Bio Pha

(1)

Suzhou Wangshan Wangshui

(1)

Suzhou Xuanjing Biotechno

(1)

Suzhou Zanrong Pharmaceut

(1)

(1)

(1)

Taejoon Pharmaceutical

(1)

Taipei Medical University

(1)

Taizhou University

(1)

Taizhou Xingputai Biologi

(1)

Takeda Pharmaceuticals

(1)

Tarim University

(1)

Tasly Pharm Group Co Ltd

(1)

Technical University of M

(1)

Tecpharma Licensing Ag

(1)

Temple University—of Th

(1)

The Affiliated Stomatolog

(1)

The Children\'s Hospital,

(1)

The Fifth Hospital of Shi

(1)

The First Hospital of Jia

(1)

The First Hospitalof Huna

(1)

The Fourth Affiliated Hos

(1)

The Geneva Found

(1)

The Hong Kong Univ Of Sci

(1)

The Regents Of The Univ O

(1)

The Regents of The Univer

(1)

The Rockefeller Universit

(1)

The Second Affiliated Hos

(1)

The Second Affiliated Hos

(1)

The Second Affiliated Hos

(1)

The Second Affiliated Hos

(1)

The Third Affiliated Clin

(1)

The Third Affiliated Hosp

(1)

The Third Xiangya Hospita

(1)

The Univ Of Osaka

(1)

Theravance Biopharma R&D

(1)

(1)

Tianjin Kaite Pharmaceuti

(1)

Tianjin University of Sci

(1)

Tianjin University of Tec

(1)

Tianjin University of Tec

(1)

Tianjin University of Tra

(1)

Tianjin University; Cetc

(1)

Tianjin University; Clp C

(1)

Tianjin University; Elect

(1)

Tianjin University; Elect

(1)

Tianjin University; South

(1)

Tianjin University; State

(1)

Tianjin University; Tianj

(1)

Tianjin University; Tianj

(1)

Tianjin University; Univ

(1)

Tianjin University; Xiame

(1)

Tianjin University; Zheng

(1)

Tianjin Xingmei Biotechno

(1)

Tianjin Zhangxin Pharmace

(1)

Tiansheng Pharmaceutical

(1)

Tianxiang Biological Phar

(1)

Titan Pharmaceutical Co L

(1)

(1)

Tlc Nanjing Pharmaceutica

(1)

Tohoku University

(1)

Tongyitang Pharm Co Ltd

(1)

Totalfoersvarets Forsknin

(1)

Translational Health Scie

(1)

(1)

Tulex Pharmaceuticals

(1)

Univ Andres Bello [cl]; U

(1)

Univ Denmark Tech Dtu; Un

(1)

Univ Grenoble Alpes [fr];

(1)

Univ Kumamoto Nat Univ Co

(1)

Univ Wake Forest Health S

(1)

Univ Xinjiang Medical

(1)

University Hebei Medical;

(1)

University Qiqihar Medica

(1)

University of Electronic

(1)

(1)

Urgo Rech Innovation Et D

(1)

Vanda Pharmaceuticals

(1)

Vanderbilt University

(1)

Vib Vzw [be]; Univ Leuven

(1)

Wanbangde Pharmaceutical

(1)

(1)

(1)

Wanjiatang Health Ind Mei

(1)

Washington University

(1)

Country

X

China Patent News

WIPO Patent News

European Patent News

Status

X

1 - 100 of 1379 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

Qingdao Gon Science & Tech Co Ltd Files Chinese Patent Application for Nanometer Calcium Carbonate Filled Phb/pbat Blending Biodegradable Material and Preparation Method Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Qingdao Gon Science & Tech Co Ltd has filed a patent application for Nanometer Calcium Carbonate Filled Phb/pbat Blending Biodegradable Material and Preparation Method Thereof. This invention was developed by Li Yan, Li Bin, Wang Wei, Liu Jiguan, Wang Long, Guo Yijun and Mei Fengce. The patent application..

University Grenoble Alpes, Commissariat Energie Atomique, Centre Hospitalier Regional De Grenoble and Centre National de la Recherche Scientifique (CNRS) Seek Patent for a Recombin..

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- University Grenoble Alpes, Commissariat Energie Atomique, Centre Hospitalier Regional De Grenoble and Centre National de la Recherche Scientifique (CNRS) have sought patent for a Recombinant Sars-cov-2 S Glycoprotein Trimer, Proteoliposomes Comprising Such a Trimer and Their Use as a Vaccine. This invention w..

European Patent Office Releases Shanghai Henlius Biotech Inc and Shanghai Henlius Biologics Co Ltd Patent Application for Anti-epidermal Growth Factor Receptor (EGFR) Antibody-drug..

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has released Shanghai Henlius Biotech Inc and Shanghai Henlius Biologics Co Ltd patent application for Anti-epidermal Growth Factor Receptor (EGFR) Antibody-drug Conjugate and Use Thereof. This invention was developed by Shan Yongqiang, Song Hongbin, Song Ge, Jiang Jiahao and Zhang Went..

European Patent Office Receives Shanghai Henlius Biotech Inc and Shanghai Henlius Biologics Co Ltd Patent Application for Anti-pdl1 Antibody-drug Conjugate and Use

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has received Shanghai Henlius Biotech Inc and Shanghai Henlius Biologics Co Ltd patent application for Anti-pdl1 Antibody-drug Conjugate and Use. Shan Yongqiang, Song Hongbin, Song Ge, Jiang Jiahao and Zhang Wentao developed the invention. The patent application number is EP202408030..

University Kumamoto Nat University Corp and Eisai R&D Management Submit Patent Application for Pharmaceutical Composition

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- University Kumamoto Nat University Corp and Eisai R&D Management have submitted a patent application for Pharmaceutical Composition. Matsuoka Masao, Yasunaga Jun-ichirou, Suzuki Yuta, Kubara Kenji and Miyazaki Takayuki developed the invention. The patent application number is EP20240807168 20240510. The pa..

Administracion General De La Comunidad Autonoma De Euskadi Submits Patent Application for Compositions Comprising Manganese for Use in the Treatment of a Neurodegenerative Disease

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Administracion General De La Comunidad Autonoma De Euskadi has submitted a patent application for Compositions Comprising Manganese for Use in the Treatment of a Neurodegenerative Disease. Holt Ian, López De Arbina Amaia and Spinazzola Antonella developed the invention. The patent application number is EP..

Lee Geon Moo, Lee In Seong, Lee Jun Seong and Chung Mi Boon Submit Patent Application for Antiviral Infusion Composition

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Lee Geon Moo, Lee In Seong, Lee Jun Seong and Chung Mi Boon have submitted a patent application for Antiviral Infusion Composition. The patent application number is EP20230936672 20230508. The patent publication number is EP4710929 (A1). International Patent Classification codes are A61K31/198, A61K31/700..

European Patent Office Receives Oblita Therapeutics Bvba Patent Application for Oleylphosphocholine in the Treatment of Leishmaniasis

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has received Oblita Therapeutics Bvba patent application for Oleylphosphocholine in the Treatment of Leishmaniasis. Jansen Caroline developed the invention. The patent application number is EP20240200310 20240913. The patent publication number is EP4710927 (A1). International Patent ..

European Patent Office Releases Leal Therapeutics Inc Patent Application for Small Molecule Inhibitors of Glutaminase

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has released Leal Therapeutics Inc patent application for Small Molecule Inhibitors of Glutaminase. This invention was developed by Abeliovich Asa, Heckman Laura, Shi Xianglin, Cheng Yunxing, Liu Xiongcai and Ashwell Mark. The patent application number is EP20240804295 20240509. The ..

Futura SRL Submits Patent Application for Compositions Comprising Gastrodin and Vitamin D and Uses Thereof

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Futura SRL has submitted a patent application for Compositions Comprising Gastrodin and Vitamin D and Uses Thereof. Uberti Francesca developed the invention. The patent application number is EP20240732770 20240509. The patent publication number is EP4709368 (A1). International Patent Classification codes a..

Fitabeo Therapeutics Ltd Submits Patent Application for Oral Thin Film Formulations

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Fitabeo Therapeutics Ltd has submitted a patent application for Oral Thin Film Formulations. Al-obaidi Issraa Rasheed and Mullen Alexander Balfour developed the invention. The patent application number is EP20240727810 20240509. The patent publication number is EP4709362 (A1). International Patent Classifi..

Maria Clementine Martin Klosterfrau Vertriebsges MBH Submits Patent Application for Multiphase Tablet Having Sleep-promoting Effect

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Maria Clementine Martin Klosterfrau Vertriebsges MBH has submitted a patent application for Multiphase Tablet Having Sleep-promoting Effect. Bartel Sven, Hülsmann Olaf, Erbe Thorsten and Marie André developed the invention. The patent application number is EP20240742947 20240715. The patent publication n..

Elite Pharmaceutical Solution Inc Submits European Patent Application for Oral Dosage Forms of Metformin and Preparation Method Thereof

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Elite Pharmaceutical Solution Inc has submitted a patent application for Oral Dosage Forms of Metformin and Preparation Method Thereof. This invention was developed by Tian Wu, Wang Yan and Tian Henry. The patent application number is EP20230936749 20230510. The patent publication number is EP4709359 (A1)...

MRX Medical Ltd Submits European Patent Application for Cannabinoid-based Formulation

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- MRX Medical Ltd has submitted a patent application for Cannabinoid-based Formulation. This invention was developed by Morgan Charles, Sturgess Melissa and Clarkson Nicholas. The patent application number is EP20240727487 20240510. The patent publication number is EP4709355 (A1). International Patent Classi..

European Patent Office Publishes MRX Medical Ltd Patent Application for Cannabinoid-based Formulation

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has published MRX Medical Ltd patent application for Cannabinoid-based Formulation. The invention was developed by Morgan Charles, Sturgess Melissa and Clarkson Nicholas. The patent application number is EP20240726956 20240510. The patent publication number is EP4709354 (A1). Interna..

European Patent Office Releases Guarnieri Michael Patent Application for Injectable Sustained Release Buprenorphine Formulation

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has released Guarnieri Michael patent application for Injectable Sustained Release Buprenorphine Formulation. The patent application number is EP20240728814 20240502. The patent publication number is EP4709353 (A1). International Patent Classification codes are A61K31/485, A61K47/14, ..

Icon Therapeutics Inc Submits Patent Application for Nucleus Localization Using Machine Learning Based Inference and Segmentation

Pharmaceutical

| Sun 22 Mar 2026

Beijing, March 23 -- Icon Therapeutics Inc has submitted a patent application for Nucleus Localization Using Machine Learning Based Inference and Segmentation. Mason Bretan and Deljuch Armin developed the invention. The patent application number is CN20248021647 20240208. The patent publication number is CN120883255 (A). Inte..

State Intellectual Property Office of China Releases Jiangsu Kangbaide Pharmaceutical New Mat Co Ltd Patent Application for Preparation Method and Application of Microcrystalline C..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has released Jiangsu Kangbaide Pharmaceutical New Mat Co Ltd patent application for Preparation Method and Application of Microcrystalline Cellulose with High Compressibility. This invention was developed by Xiao Wensen, Cao Jin and Chen Yong. The patent applica..

Cytotech Biopharma Inc Applies for Patent on Novel Il-15 Fusion Protein and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Cytotech Biopharma Inc has applied Chinese patent for Novel Il-15 Fusion Protein and Application Thereof. Yan Zhonghui, Gu Songhai, He Lihua, Liu Weichun, Yue Chaomin, He Yurou, Cai Zhenzhen and Zhang Yili developed it. The patent application number is CN202511440001 20251010. The patent publication numbe..

State Intellectual Property Office of China Receives Beijing Xinchuang Biological Eng Co Ltd Patent Application for Hepatitis C Antibody Detection Antigen Composition as Well as Ap..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has received Beijing Xinchuang Biological Eng Co Ltd patent application for Hepatitis C Antibody Detection Antigen Composition as Well as Application, Kit and Detection Method Thereof. Li Long, Meng Tingting, Jing Yingying and Zhu Yuexian developed the invention. ..

Northwest A&F University Shenzhen Research Institute Seeks Patent for Nano Antibody Specifically Bound with Pig Igm Fc Receptor FC [mu] R or Antigen Binding Fragment Thereof and Ap..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Northwest A&F University Shenzhen Research Institute has sought patent for Nano Antibody Specifically Bound with Pig Igm FC Receptor Fc [mu] R or Antigen Binding Fragment Thereof and Application of Nano Antibody or Antigen Binding Fragment. This invention was developed by Liu Jianqi, Sun Xiangyu, Jin Huiming..

State Intellectual Property Office of China Receives Wuhan Abclonal Co Ltd Patent Application for Monoclonal Antibody of Anti-human Nkp30 Protein and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has received Wuhan Abclonal Co Ltd patent application for Monoclonal Antibody of Anti-human Nkp30 Protein and Application Thereof. Liu Xiaoyu, Wu Hai, Yu Xiujuan, Chen Lu, Wang Xue and Yang Hengsong developed the invention. The patent application number is CN202..

Beijing Rongai Medical Biotechnology Co Ltd Applies for Patent on Targeting Claudin 18.2 Nano Antibody and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Beijing Rongai Medical Biotechnology Co Ltd has applied Chinese patent for Targeting Claudin 18.2 Nano Antibody and Application Thereof. Zhang Haiyan, Zhang Shengnan, Ma Yahui, Li Jianying, Yang Danhui, Wei Ying, Wu Weihai and Niu Lincan developed it. The patent application number is CN202511104107 202411..

State Intellectual Property Office of China Publishes Beijing Rongai Medical Biotechnology Co Ltd Patent Application for Targeting Claudin 18.2 Nano Antibody and Application Thereo..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Beijing Rongai Medical Biotechnology Co Ltd patent application for Targeting Claudin 18.2 Nano Antibody and Application Thereof. The invention was developed by Zhang Haiyan, Zhang Shengnan, Ma Yahui, Li Jianying, Yang Danhui, Wei Ying, Wu Weihai and N..

Beijing Rongai Medical Biotechnology Co Ltd Submits Patent Application for Targeting Claudin 18.2 Nano Antibody and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Beijing Rongai Medical Biotechnology Co Ltd has submitted a patent application for Targeting Claudin 18.2 Nano Antibody and Application Thereof. Zhang Haiyan, Zhang Shengnan, Li Jianying, Ma Yahui, Yang Danhui, Wei Ying, Wu Weihai and Niu Lincan developed the invention. The patent application number is CN..

Shanghai Chengfan Pharmaceutical Co Ltd Submits Chinese Patent Application for Therapeutic Anti-IGF-1R and TSHR Bispecific Antibody and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Shanghai Chengfan Pharmaceutical Co Ltd has submitted a patent application for Therapeutic Anti-IGF-1R and TSHR Bispecific Antibody and Application Thereof. This invention was developed by Wang Wei, Li Jing, Xu Man and Lu Shuang. The patent application number is CN202510578918 20250505. The patent publica..

Tianjin Xingmei Biotechnology Co Ltd Applies for Patent on Nano Antibody Targeting Actriib and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Tianjin Xingmei Biotechnology Co Ltd has applied Chinese patent for Nano Antibody Targeting Actriib and Application Thereof. An Maomao, Cui Zhiping, Zhang Xuewei, Sun Jingwen, Xie Cheng, Yu Yongming and Li Bohua developed it. The patent application number is CN202410551479 20240506. The patent publication..

State Intellectual Property Office of China Receives TLC Nanjing Pharmaceutical Res And Development Co Ltd Patent Application for Preparation Method of Pyronaphthyridine Metabolite

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has received TLC Nanjing Pharmaceutical Res And Development Co Ltd patent application for Preparation Method of Pyronaphthyridine Metabolite. Zhang Hailin, Hu Yongzhu, Zhang Chi, Liu Chun and Wang Zhongyi developed the invention. The patent application number is..

Shanghai Allist Pharmaceuticals Inc Submits Chinese Patent Application for Nitrogen-containing Heterocyclic Ring Compound as Well as Preparation Method and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Shanghai Allist Pharmaceuticals Inc has submitted a patent application for Nitrogen-containing Heterocyclic Ring Compound as Well as Preparation Method and Application Thereof. This invention was developed by Zhou Huayong, Hu Jianping and Luo Huibing. The patent application number is CN202510589701 202505..

Shandong Jths New Material Science And Tech Co Ltd Files Chinese Patent Application for Preparation Method of Printable Packaging Composite Board Formed Based on Coal Gangue and Ca..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Shandong Jths New Material Science And Tech Co Ltd has filed a patent application for Preparation Method of Printable Packaging Composite Board Formed Based on Coal Gangue and Calcium Carbonate. This invention was developed by Yan Qiuling, Xuan Haihan and Xuan Wei. The patent application number is CN20251..

State Intellectual Property Office of China Receives University Hebei Medical and CSPC Zhongnuo Pharmaceutical Shijiazhuang Co Ltd Patent Application for Mn-fe Bimetallic Magnetic ..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has received University Hebei Medical and CSPC Zhongnuo Pharmaceutical Shijiazhuang Co Ltd patent application for Mn-fe Bimetallic Magnetic Coconut Shell Charcoal Composite Material as Well as Preparation Method and Application Thereof. Liu Yuheng, Niu Xiaoxue, Zho..

PTC Therapeutics HD Inc Files European Patent Application for Crystalline Forms of 2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)-3h-[1,2,3]triazolo[4,5-c]pyridazin-6-yl]-5-(2h-1,2,3-tri..

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- PTC Therapeutics HD Inc has filed a patent application for Crystalline Forms of 2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)-3h-[1,2,3]triazolo[4,5-c]pyridazin-6-yl]-5-(2h-1,2,3-triazol-2-yl)phenol. This invention was developed by Shu Lianhe. The patent application number is EP20240735359 20240503. The patent ..

European Patent Office Publishes Integro Theranostics LLC Patent Application for Lyophilized Products, Pharmaceutical Compositions, and Kits Comprising Dye-peptide Conjugates and D..

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has published Integro Theranostics LLC patent application for Lyophilized Products, Pharmaceutical Compositions, and Kits Comprising Dye-peptide Conjugates and Derivatives. The invention was developed by Thompson Daniel J, Cudney Brian, Phravorachith Phouthone and Murray Autumn D. Th..

Ascendis Pharma Oncology Div A/S Files European Patent Application for Novel Cancer Treatments with IL-2 Conjugates

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Ascendis Pharma Oncology Div A/S has filed a patent application for Novel Cancer Treatments with IL-2 Conjugates. This invention was developed by Miller Breinholt Vibeke, Singel Stina, Lança Telma, Kurpiers Thomas and Knappe Thomas. The patent application number is EP20240725777 20240508. The patent publi..

The Geneva Found Files European Patent Application for Andes Virus Variants, Pharmaceutical Compositions, and Methods of Treatment Relating Thereto

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- The Geneva Found has filed a patent application for Andes Virus Variants, Pharmaceutical Compositions, and Methods of Treatment Relating Thereto. This invention was developed by Hooper Jay W and Brocato Rebecca. The patent application number is EP20240824017 20240611. The patent publication number is EP470..

Canopy Immuno Therapeutics Ltd Submits European Patent Application for Ig-like Fusion Proteins for Treating Immune Thrombocytopenia

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Canopy Immuno Therapeutics Ltd has submitted a patent application for Ig-like Fusion Proteins for Treating Immune Thrombocytopenia. This invention was developed by Oved Kfir, Denkberg Galit, Reef Sharon, Pinzur Yelena and Arman Zelman Inbar. The patent application number is EP20240803211 20240508. The pate..

Hemostod Sa Files European Patent Application for Method for Producing Therapeutic RNA Platelet Vehicles

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Hemostod Sa has filed a patent application for Method for Producing Therapeutic RNA Platelet Vehicles. This invention was developed by Burnier Laurent, Humbert Magali and Rocca Céline. The patent application number is EP20240728016 20240506. The patent publication number is EP4709397 (A1). International P..

Urgo Rech Innovation Et Developpement Applies for Patent on Use of Oligosaccharide Compounds for Preventing the Recurrence of Neuro-ischemic Wounds in Diabetic Patients

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Urgo Rech Innovation Et Developpement has applied European patent for Use of Oligosaccharide Compounds for Preventing the Recurrence of Neuro-ischemic Wounds in Diabetic Patients. Bohbot Serge and Lazaro Martinez Jose Luis developed it. The patent application number is EP20240730735 20240507. The patent pu..

European Patent Office Releases 11949098 Canada Inc Patent Application for Inverse Agonists of Rar Related Orphan Receptors (RORS)

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has released 11949098 Canada Inc patent application for Inverse Agonists of Rar Related Orphan Receptors (RORS). This invention was developed by Fouda Ahmed, Tchervenkov Jean, Paraskevas Steven, Negi Sarita and Cools-lartigue Jonathan. The patent application number is EP20240802479 2..

State Intellectual Property Office of China Publishes Alia Therapeutics Ltd Patent Application for Type II Cas Protein and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Alia Therapeutics Ltd patent application for Type II Cas Protein and Application Thereof. The invention was developed by Casini Antonio, Pejser Lukas, Cicciani Marco, Saracino Aldo, Bertolini Stefano and Bossetti Matteo. The patent application numb..

Baifang Yingku Pharmaceutical Tech Beijing Co Ltd Applies for Patent on Anti-GPRC5D Nano Antibody and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Baifang Yingku Pharmaceutical Tech Beijing Co Ltd has applied Chinese patent for Anti-GPRC5D Nano Antibody and Application Thereof. Yuan Daopeng, Wu Chunyan, Zhang Hui and Zhu Jie developed it. The patent application number is CN20238095956 20230322. The patent publication number is CN120882747 (A). Inter..

Wuhan Hi Life Medical Science & Tech Co Ltd Submits Patent Application for Driving Circuit, Therapeutic Apparatus and Driving Circuit Modulation Method of Therapeutic Apparatus

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Wuhan Hi Life Medical Science & Tech Co Ltd has submitted a patent application for Driving Circuit, Therapeutic Apparatus and Driving Circuit Modulation Method of Therapeutic Apparatus. Pan Xiaohai, Xu Pingjie, Yang Haiyan and Wang-zhang Guiyi developed the invention. The patent application number is CN20..

State Intellectual Property Office of China Publishes Hybio Pharmaceutical Co Ltd Patent Application for Method for Improving Stability and Solubility of New Crown Antigen Peptide

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Hybio Pharmaceutical Co Ltd patent application for Method for Improving Stability and Solubility of New Crown Antigen Peptide. The invention was developed by Huang Jiacheng, Lu Xiaojie, Tang Renjin, Tang Yangming and Yu Pinxiang. The patent applica..

State Intellectual Property Office of China Releases SPH No. 1 Biochemical & Pharmaceutical Co Ltd Patent Application for Preparation Method of Sodium Tanshinone Iia Sulfonate, Cry..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has released SPH No. 1 Biochemical & Pharmaceutical Co Ltd patent application for Preparation Method of Sodium Tanshinone Iia Sulfonate, Crystal Form of Sodium Tanshinone Iia Sulfonate and Pharmaceutical Composition. This invention was developed by Yu Wei, Liu Yan,..

State Intellectual Property Office of China Publishes Acerta Pharmaceuticals Inc Patent Application for Process for Preparation of Arrabutinib

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Acerta Pharmaceuticals Inc patent application for Process for Preparation of Arrabutinib. The invention was developed by Bethel Paul A, Chen Leslie C, Cooper Katherine G, Cox Richard J, Gordon Mark David, Hughes Simon Alan, Jackson Logan V, Millard Ke..

State Intellectual Property Office of China Publishes Nanjing Gentai Pharmaceutical Tech Co Ltd Patent Application for Atr and Parp1 Double-target Inhibitor

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Nanjing Gentai Pharmaceutical Tech Co Ltd patent application for Atr and Parp1 Double-target Inhibitor. The invention was developed by Xiao Dengming. The patent application number is CN20241073068 20240118. The patent publication number is CN120904..

State Intellectual Property Office of China Publishes Shanghai Zedeman Medical Tech Co Ltd Patent Application for Compound with Fused Ring Structure and Application of Compound in ..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Shanghai Zedeman Medical Tech Co Ltd patent application for Compound with Fused Ring Structure and Application of Compound in Medicine. The invention was developed by Chen Genghui, Cai Yaxian, Han Zixing, Cai Kaiming, Xu Jiajia and Jia Jianmin. The..

Changzhou Yabang Pharmaceutical Co Ltd Applies for Patent on Azilsartan Impurity M as Well as Preparation Method and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Changzhou Yabang Pharmaceutical Co Ltd has applied Chinese patent for Azilsartan Impurity M as Well as Preparation Method and Application Thereof. Wang Haonan, Ji Suxiang, Yu Shuitao, Chen Song, Zhang Zhimin, Wang Yongjun and Wang Bin developed it. The patent application number is CN20251108710 20250722. ..

Zhejiang Yangli Medicine Tech Co Ltd Submits Chinese Patent Application for N-alkoxy Acetamide Compound as Well as Pharmaceutical Composition and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Zhejiang Yangli Medicine Tech Co Ltd has submitted a patent application for N-alkoxy Acetamide Compound as Well as Pharmaceutical Composition and Application Thereof. This invention was developed by Liu Yang, Li Jianyong, Wu Linlin, Zhou Ji, Zhang Haolong, Ding Zhaozhong, Fang Dong and Sha Wei. The patent..

State Intellectual Property Office of China Releases Shanghai Yizhong Pharmaceutical and Shanghai Youxichuang Pharmaceutical Tech Co Ltd Patent Application for Fourth-generation EG..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has released Shanghai Yizhong Pharmaceutical and Shanghai Youxichuang Pharmaceutical Tech Co Ltd patent application for Fourth-generation EGFR (epidermal Growth Factor Receptor) Inhibitor as Well as Preparation Method and Pharmaceutical Application Thereof. This in..

Jisikai Suzhou Pharmaceutical Co Ltd Submits Chinese Patent Application for Compound with Indazole Group, Thrbeta Receptor Agonist and Application

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Jisikai Suzhou Pharmaceutical Co Ltd has submitted a patent application for Compound with Indazole Group, Thrbeta Receptor Agonist and Application. This invention was developed by Zhang Huajie, Qi Yangli, Wang Xianlong, Zhang Weipeng, Liu Qihong, Jiang Lihua, Qin Yu, Zhang Bei, Hu Yuanyuan, Zhao Xingdong and..

State Intellectual Property Office of China Releases Henan Radiomedical Pharmaceutical Tech Co Ltd and Shanghai Liangyu Jinquan Biotechnology Co Ltd Patent Application for 1-methyl..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has released Henan Radiomedical Pharmaceutical Tech Co Ltd and Shanghai Liangyu Jinquan Biotechnology Co Ltd patent application for 1-methyl-6-aryl Indole-2-formamide Derivative as Well as Preparation Method and Application Thereof. This invention was developed by ..

Aurisco Pharmaceutical Tianjin Co Ltd Submits Chinese Patent Application for Preparation Method of Olbiteb and Intermediate Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Aurisco Pharmaceutical Tianjin Co Ltd has submitted a patent application for Preparation Method of Olbiteb and Intermediate Thereof. This invention was developed by Dong Jinfu, Wu Yuzhuo, Guo Wancheng, Fang Jie, Chu Dingjun and Xie Xiaoqiang. The patent application number is CN20251132426 20250725. The pa..

Hanghzou Bio Sincerity Pharma Tech Cop Ltd Seeks Patent for Benzoheterocyclic Compound and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Hanghzou Bio Sincerity Pharma Tech Cop Ltd has sought patent for Benzoheterocyclic Compound and Application Thereof. This invention was developed by Feng Enguang, Jia Fei, Qin Jinjing, Jin Lifeng, Kanazawa Takeru, Xiong Xiaohong, Li Yuanyuan, Cheng Didi and Lou Jinfang. The patent application number is CN..

State Intellectual Property Office of China Publishes Zhongke Zhongshan Pharmaceutical Innovation Res Institute Patent Application for Silver Salt Thiacrown Ether Complex as Well a..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Zhongke Zhongshan Pharmaceutical Innovation Res Institute patent application for Silver Salt Thiacrown Ether Complex as Well as Preparation Method and Application Thereof. The invention was developed by Zhang Jiabin, Xia Ru and She Seng. The patent..

Shanghai Xudong Haipu Jiading Pharmaceutical Factory Seeks Patent for Preparation Method of Flunarizine Hydrochloride

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Shanghai Xudong Haipu Jiading Pharmaceutical Factory has sought patent for Preparation Method of Flunarizine Hydrochloride. This invention was developed by Chen Xiaolin, Bi Guangqing, Wang Shanshan, Zhan Yafeng, Zhao Weizhong and Wu Liming. The patent application number is CN202510992785 20250718. The pat..

Hunan Asidikang Pharmaceutical Co Ltd Applies for Patent on Efficient Catalysis Process of Phenylimidazole Derivative

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Hunan Asidikang Pharmaceutical Co Ltd has applied Chinese patent for Efficient Catalysis Process of Phenylimidazole Derivative. Peng Wei and Huang Yin developed it. The patent application number is CN202511431567 20251009. The patent publication number is CN120904115 (A). International Patent Classificati..

Tianxiang Biological Pharmaceutical Xingtai Co Ltd Files Chinese Patent Application for Preparation Method of Tiamulin and Tiamulin Fumarate Based on Bunte Salt

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Tianxiang Biological Pharmaceutical Xingtai Co Ltd has filed a patent application for Preparation Method of Tiamulin and Tiamulin Fumarate Based on Bunte Salt. This invention was developed by Mei Yulong, Li Yonghui, Wang Wu, Gao Yuanyuan, Yan Mengshuan, Liu Yichao and Ning Hongli. The patent application n..

State Intellectual Property Office of China Publishes Suzhou No. 4 Pharmaceutical Factory Co Ltd Patent Application for Method for Continuously Preparing (2r, 4s)-5-(biphenyl-4-yl)..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Suzhou No. 4 Pharmaceutical Factory Co Ltd patent application for Method for Continuously Preparing (2r, 4s)-5-(biphenyl-4-yl)-4-[(tert-butoxycarbonyl) Amino]-2-methylpentanoic Acid. The invention was developed by Xu Honglei, Zheng Ming and Liu Junyin..

Lunan Pharmaceutical Group Corp Submits Chinese Patent Application for Melogabalin-malic Acid Crystal Form and Preparation Method Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Lunan Pharmaceutical Group Corp has submitted a patent application for Melogabalin-malic Acid Crystal Form and Preparation Method Thereof. This invention was developed by Zhai Lihai, Lu Laiju, Zhang Mingming and Xia Xianglai. The patent application number is CN20251134741 20250725. The patent publication ..

State Intellectual Property Office of China Releases Yangtze River Delta Medical Advanced Tech Innovation Center Patent Application for Amino Lipid Compound, Lipid Nanoparticles Co..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has released Yangtze River Delta Medical Advanced Tech Innovation Center patent application for Amino Lipid Compound, Lipid Nanoparticles Constructed by Amino Lipid Compound and Pharmaceutical Composition. This invention was developed by Cai Jin, Wang Peng, Zhang Y..

Hubei Zaofu Pharmaceutical Co Ltd Seeks Patent for Preparation Method of L-ornithine Hydrochloride

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Hubei Zaofu Pharmaceutical Co Ltd has sought patent for Preparation Method of L-ornithine Hydrochloride. This invention was developed by Shen Guochun, Gan Zhouyang, Ma Ling, Yu Zhihua, Zhao Yang, Liu Miaoying, Liu Jianqiao, Zhu Siwang, Hu Jie, Fan Jinmin and Hong Jibing. The patent application number is C..

Chengdu Anlite Pharmaceutical Tech Co Ltd Submits Chinese Patent Application for New Crystal Form of Menadione and Preparation Method Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Chengdu Anlite Pharmaceutical Tech Co Ltd has submitted a patent application for New Crystal Form of Menadione and Preparation Method Thereof. This invention was developed by Cao Zhi, Lu Guiqian, Chen Peng, Wu Weizhang, Wang Zhiqiao, Wang Yiqian and Lyu Liangfei. The patent application number is CN2025113..

State Intellectual Property Office of China Publishes Suzhou Haishun Packaging Mat Co Ltd Patent Application for Composite Material for Medicinal High-barrier Transparent Flexible ..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Suzhou Haishun Packaging Mat Co Ltd patent application for Composite Material for Medicinal High-barrier Transparent Flexible Package and Preparation Method of Composite Material. The invention was developed by Lin Wuhui, Hu Jingci and Wang Zirun. ..

Jiuzhou Hehui Changzhou Pharmaceutical Equipment Co Ltd Seeks Patent for Membrane Separation Pure Water Preparation Device

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Jiuzhou Hehui Changzhou Pharmaceutical Equipment Co Ltd has sought patent for Membrane Separation Pure Water Preparation Device. This invention was developed by Jiang Bin, Gong Kangmin and Wang Weicheng. The patent application number is CN202511355672 20250922. The patent publication number is CN120903638..

Hebei Kainuo Pharmaceutical Co Ltd Applies for Patent on Wastewater Treatment Equipment for Traditional Chinese Medicine Processing

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Hebei Kainuo Pharmaceutical Co Ltd has applied Chinese patent for Wastewater Treatment Equipment for Traditional Chinese Medicine Processing. Liu Bing, Xue Zhaoqiang and Li Zhilei developed it. The patent application number is CN202511304234 20250912. The patent publication number is CN120903624 (A). Inte..

Yantai Healing Tech Co Ltd Submits Patent Application for Mechanical Arm for Plasma Therapeutic Apparatus

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Yantai Healing Tech Co Ltd has submitted a patent application for Mechanical Arm for Plasma Therapeutic Apparatus. Zhao Long, He Guirong, Wang Jian, Song Pengfei, Wang Jianyu, Lin Weixing, Sun Xiaopeng and Hua Li developed the invention. The patent application number is CN202511327010 20250917. The patent..

State Intellectual Property Office of China Receives Jiangxi Health Pharmaceutical Co Ltd and Jiangxi Dankang Pharmaceutical Co Ltd Patent Application for Intelligent Packaging Equ..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has received Jiangxi Health Pharmaceutical Co Ltd and Jiangxi Dankang Pharmaceutical Co Ltd patent application for Intelligent Packaging Equipment for Lactulose Oral Solution Processing. Wang Ning developed the invention. The patent application number is CN20251..

State Intellectual Property Office of China Releases Zhongmei Huayi Hebei Pharmaceutical Co Ltd Patent Application for Continuous Capsule Aluminum Foil Plate Packaging and Transpor..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has released Zhongmei Huayi Hebei Pharmaceutical Co Ltd patent application for Continuous Capsule Aluminum Foil Plate Packaging and Transporting Device. This invention was developed by Chen Hui, Xing Liang, Gao Wei, Dou Zhanfu and Tao Yuxiang. The patent applica..

State Intellectual Property Office of China Receives Nantong Han Di Automation Equipment Patent Application for Medicament Bottle Anti-jamming Sorting Device Based on Visual Inspec..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has received Nantong Han Di Automation Equipment patent application for Medicament Bottle Anti-jamming Sorting Device Based on Visual Inspection and Using Method Thereof. Huang Binfeng and Liu Lei developed the invention. The patent application number is CN20251..

European Patent Office Releases Gencc GmbH & Co KG Patent Application for Method for the Manufacture of Individualized Crispr/cas Complexes and Individualized CRISPR/cas Complexes

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has released Gencc GmbH & Co KG patent application for Method for the Manufacture of Individualized Crispr/cas Complexes and Individualized CRISPR/cas Complexes. This invention was developed by Wilkens Bodo, Macarrón Palacios Arturo, Korus Patrick and Heshmatpour Najmeh. The patent ..

Peg Bio Biopharm Co Ltd Chongqing Applies for Patent on Phenylalanine Lyase Mutant, and Conjugate Thereof or Pharmaceutically Acceptable Salt Thereof

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Peg Bio Biopharm Co Ltd Chongqing has applied European patent for Phenylalanine Lyase Mutant, and Conjugate Thereof or Pharmaceutically Acceptable Salt Thereof. Fan Kai, Fu Zhicheng, Tang Guanghui, Wu Kuncan, Zeng Xin, Luan Qiuyang, Liu Riyong and Chen Qing developed it. The patent application number is EP..

European Patent Office Publishes Shujing Biopharma Co Ltd and Jiangsu Nhwa Pharmaceutical Patent Application for Steroid Compound, Preparation Method Therefor, and Use Thereof

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has published Shujing Biopharma Co Ltd and Jiangsu Nhwa Pharmaceutical patent application for Steroid Compound, Preparation Method Therefor, and Use Thereof. The invention was developed by Feng Jiaquan, Shi Junjie, Zou Yuanhai and Wan Zehong. The patent application number is EP202408..

European Patent Office Publishes Gan & Lee Pharmaceuticals Co Ltd Patent Application for Camptothecin Derivative, Linker, Ligand-drug Conjugate and Medical Use Thereof

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has published Gan & Lee Pharmaceuticals Co Ltd patent application for Camptothecin Derivative, Linker, Ligand-drug Conjugate and Medical Use Thereof. The invention was developed by Sun Yingjie, Cui Menghan, Jiao Jiao, Wang Jiaxing, Che Liming, Zhang Guofu and Chen Wen. The patent ..

European Patent Office Releases Chengdu Cynogen Bio Pharmaceutical Tech Co Ltd Patent Application for 1h-[1,2,3]triazolo[4,5-h]quinazoline Compounds as Protein Kinase Inhibitors

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has released Chengdu Cynogen Bio Pharmaceutical Tech Co Ltd patent application for 1h-[1,2,3]triazolo[4,5-h]quinazoline Compounds as Protein Kinase Inhibitors. This invention was developed by Cheng Hang, Xiong Weiyan, Shi Pengyi, Niu Wei, Yu Bin and Jiang Yu. The patent application n..

European Patent Office Publishes Mindrank Ai Ltd Patent Application for Pyrimido Macroheterocyclic Compound as WEE1-YES Dual-target Inhibitor and Use Thereof

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has published Mindrank Ai Ltd patent application for Pyrimido Macroheterocyclic Compound as WEE1-YES Dual-target Inhibitor and Use Thereof. The invention was developed by Zhang Long and Niu Zhangming. The patent application number is EP20240803086 20240510. The patent publication num..

European Patent Office Receives Pharmaengine Inc Patent Application for Fused Pyrrole Ring or Fused Pyridine Ring Compound

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has received Pharmaengine Inc patent application for Fused Pyrrole Ring or Fused Pyridine Ring Compound. Liu Cheng-hao, Lin Long-zhi, Wang Hong-ren, Xun Guoliang, Sun Yina, Yang Jinyu, Zhou Jianlai and Chen Bin developed the invention. The patent application number is EP20240806458 2..

European Patent Office Receives Jiangsu Hengrui Pharmaceuticals Co Ltd and Tianjin Hengrui Medicine Co Ltd Patent Application for Ligand Targeting Fibroblast Activation Protein

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has received Jiangsu Hengrui Pharmaceuticals Co Ltd and Tianjin Hengrui Medicine Co Ltd patent application for Ligand Targeting Fibroblast Activation Protein. Zhou Shunguang, Ge Xinyue, Sun Jiyun, Li Zhongqing, Song Zihui, Zhang Mengyi and Guo Feihu developed the invention. The paten..

Nain Biotech Hangzhou Co Ltd Seeks Patent for Tetrahydrocarbazole Derivative, Pharmaceutical Composition, and Use Thereof

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Nain Biotech Hangzhou Co Ltd has sought patent for Tetrahydrocarbazole Derivative, Pharmaceutical Composition, and Use Thereof. This invention was developed by Wang Yingjie and Jia Wei. The patent application number is EP20240803009 20240508. The patent publication number is EP4711356 (A1). International P..

Evox Therapeutics Ltd Seeks Patent for Improved CRISPR/cas Guide RNA (GRNA)

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Evox Therapeutics Ltd has sought patent for Improved CRISPR/cas Guide RNA (GRNA). This invention was developed by Liang Xiuming, Zhou Houze, Nordin Joel, Gupta Dhanu, El Andaloussi Samir and Nizamudeen Zubair. The patent application number is EP20240730192 20240513. The patent publication number is EP47098..

Vib VZW, University Leuven Kath and Vrije Universiteit Brussel Submit Patent Application for Slc4a4/nbce1 Inhibitors

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Vib VZW, University Leuven Kath and Vrije Universiteit Brussel have submitted a patent application for Slc4a4/nbce1 Inhibitors. Mazzone Massimiliano, Orban Marie-pauline, Brunner Janine, Schenk Stephan, Dombrecht Bruno, Langenberg Tobias, Curcio Michele and Hassanzadeh Ghassabeh Gholamreza developed the inven..

European Patent Office Receives Canopy Immuno Therapeutics Ltd Patent Application for Ig-like Fusion Proteins for Treating Membranous Nephropathy

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has received Canopy Immuno Therapeutics Ltd patent application for Ig-like Fusion Proteins for Treating Membranous Nephropathy. Oved Kfir, Denkberg Galit, Reef Sharon, Pinzur Yelena and Arman Zelman Inbar developed the invention. The patent application number is EP20240803209 2024050..

Ranok Therapeutics Hangzhou Co Ltd Submits European Patent Application for Methods and Compositions for Targeted Protein Degradation

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Ranok Therapeutics Hangzhou Co Ltd has submitted a patent application for Methods and Compositions for Targeted Protein Degradation. This invention was developed by Ying Chenghao, Wang Guoqiang, Wang Zhiyong, Yang Zimo, Li Jinhua, Wang Yaya, Dai Yan, Ying Weiwen and Foley Kevin P. The patent application nu..

Progentos Therapeutics Inc Submits European Patent Application for Heterocyclic Compounds and Uses Thereof

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Progentos Therapeutics Inc has submitted a patent application for Heterocyclic Compounds and Uses Thereof. This invention was developed by Magavi Sanjay Shivayogi, Parks Daniel J, Tait Bradley Dean, Cho Jinhyung, Kolpak Adrianne and Shaw Patricia R. The patent application number is EP20240729679 20240508. ..

European Patent Office Publishes Jazz Pharmaceuticals Research UK Ltd Patent Application for Anticonvulsive Compounds and Uses Thereof

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- European Patent Office has published Jazz Pharmaceuticals Research UK Ltd patent application for Anticonvulsive Compounds and Uses Thereof. The invention was developed by Di Fruscia Paolo, Hinchliffe Paul Stuart, Simpson Iain David and Peach Joanne. The patent application number is EP20240727816 20240510. ..

Modulo Bio Inc Seeks Patent for 5-cyano-1h-imidazole-2-carboxamide Compounds as Csf1r Inhibitors

Pharmaceutical

| Sun 22 Mar 2026

Munich, March 23 -- Modulo Bio Inc has sought patent for 5-cyano-1h-imidazole-2-carboxamide Compounds as Csf1r Inhibitors. This invention was developed by Burgess Laurence, Mackenzie Lloyd, Harwig Curtis and Saccomano Nicholas. The patent application number is EP20240742713 20240607. The patent publication number is EP4709719..

Suzhou Xuanjing Biotechnology Co Ltd Files Chinese Patent Application for Compound for Inhibiting Agt Gene Expression, Pharmaceutical Composition and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Suzhou Xuanjing Biotechnology Co Ltd has filed a patent application for Compound for Inhibiting Agt Gene Expression, Pharmaceutical Composition and Application Thereof. This invention was developed by Huang Yuanyu, Li Haitao, Kong Lina and Han Xiaofeng. The patent application number is CN20248019616 20240..

Suzhou Zanrong Pharmaceutical Tech Co Ltd Submits Chinese Patent Application for KRAS G12d Inhibitors and Uses Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Suzhou Zanrong Pharmaceutical Tech Co Ltd has submitted a patent application for KRAS G12d Inhibitors and Uses Thereof. This invention was developed by Wang Zheng, Zhou Ding and Cheng Ziqiang. The patent application number is CN20248008490 20240117. The patent publication number is CN120882724 (A). Intern..

Shuangyi Original Shanghai Pharmaceutical Co Ltd Seeks Patent for Arf1 Inhibitor and Application Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Shuangyi Original Shanghai Pharmaceutical Co Ltd has sought patent for Arf1 Inhibitor and Application Thereof. This invention was developed by Hou Xianyu, Wang Yuetong, Luo Chenfei, Li Haisen and Huang Zhigang. The patent application number is CN20248018185 20240726. The patent publication number is CN120..

State Intellectual Property Office of China Receives Shanghai Qilu Pharmaceutical Res Center Co Ltd Patent Application for Itentecan Derivative and Antibody Drug Conjugate Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has received Shanghai Qilu Pharmaceutical Res Center Co Ltd patent application for Itentecan Derivative and Antibody Drug Conjugate Thereof. Wang Junfei, Bi Xiaoyang, Huang Wenshu, Wang Xinmei, Huang Ying, Yang Yang, Sun Daqing and Tao Weikang developed the inventi..

State Intellectual Property Office of China Releases Beijing Puqi Pharmaceutical Tech Co Ltd Patent Application for Preparation Method of Pyrrolopyrimidine Compound or Pharmaceutic..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has released Beijing Puqi Pharmaceutical Tech Co Ltd patent application for Preparation Method of Pyrrolopyrimidine Compound or Pharmaceutically Acceptable Salt Thereof. This invention was developed by Han Junru, Lei Fei, Ma Sufeng, Wang Zhen, Hu Wei and Zhu Li. ..

Wind Tree Therapeutics Inc Applies for Patent on Solid Forms of {5-cyclopropyl-2-[2-(3, 6-difluoro-pyridin-2-ylamino)-pyridin-4-yl]-pyrido [3, 4-d] Pyrimidin-4-yl}-((s)-3, 3-dimeth..

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Wind Tree Therapeutics Inc has applied Chinese patent for Solid Forms of {5-cyclopropyl-2-[2-(3, 6-difluoro-pyridin-2-ylamino)-pyridin-4-yl]-pyrido [3, 4-d] Pyrimidin-4-yl}-((s)-3, 3-dimethyl-piperidin-4-yl)-amine. Amedio John C developed it. The patent application number is CN20238094028 20231212. The pa..

Corden Pharma International Int GmbH Seeks Patent for New Tags for Liquid Phase Peptide Synthesis

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Corden Pharma International GmbH has sought patent for New Tags for Liquid Phase Peptide Synthesis. This invention was developed by Giraud Mathieu, Albericio Fernando, Mardel Oleg, Hoellriegl Laura, Hertenschmidt Marek, Hoegenkamp Fabian and Kramer Tim. The patent application number is CN20248019188 20240..

State Intellectual Property Office of China Publishes Tecpharma Licensing Ag Patent Application for Needle Shield Remover

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Tecpharma Licensing Ag patent application for Needle Shield Remover. The invention was developed by Hostettler Patrick, Scheurer Stefan, Allenspach Martin, Kretzli Ulrich and Zumsten Daniel. The patent application number is CN20248022506 20240325. ..

Golden Mab Co Ltd Files Chinese Patent Application for Linkers, Drug Linkers and Conjugates Thereof, and Methods of Using Same

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Golden Mab Co Ltd has filed a patent application for Linkers, Drug Linkers and Conjugates Thereof, and Methods of Using Same. This invention was developed by Liu Haidong, Wang Guobao, Jiang Xiaolong and Shang Xiao. The patent application number is CN20248018229 20240111. The patent publication number is C..

State Intellectual Property Office of China Receives Lysia Therapeutics Inc Patent Application for Circulating Lysosomal Targeting Antibody Conjugates

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has received Lysia Therapeutics Inc patent application for Circulating Lysosomal Targeting Antibody Conjugates. Linder Nina, Chen Tao, Koogentakis Christos, Lewis Jason G, Schuttleff Markus, Staben Steven, Turtle Erik D, Yao Richard, Zheng Shuai and Tran Thanh-tuan..

State Intellectual Property Office of China Publishes Embold Therapeutics Inc Patent Application for Engineered Glucocerebrosidase Variants

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- State Intellectual Property Office of China has published Embold Therapeutics Inc patent application for Engineered Glucocerebrosidase Variants. The invention was developed by Arts Jacob Hansen, Botham Rachel Kathleen, Chen Xingxiu, Francisco Victorino Miguel, Harris William Casey, Jeremiah Dallas Heredia, J..

Supermus Pharmaceuticals Inc Submits Patent Application for Derivatives of Substituted Morpholines and Uses Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Supermus Pharmaceuticals Inc has submitted a patent application for Derivatives of Substituted Morpholines and Uses Thereof. Padia Janak Khimchand and Yu Chao developed the invention. The patent application number is CN20248016440 20240326. The patent publication number is CN120882415 (A). International P..

ST Pharm Submits Chinese Patent Application for Novel Solid Dispersion and Preparation Method Thereof

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- ST Pharm has submitted a patent application for Novel Solid Dispersion and Preparation Method Thereof. This invention was developed by Kim Kyeong-jin and Kim Uk-il. The patent application number is CN20248017830 20240308. The patent publication number is CN120882408 (A). International Patent Classificatio..

Anhui Yuanjing Pharmaceutical Packaging Co Ltd Submits Patent Application for Medicinal Aluminum Bottle Processing and Spraying Equipment

Pharmaceutical

| Mon 23 Mar 2026

Beijing, March 23 -- Anhui Yuanjing Pharmaceutical Packaging Co Ltd has submitted a patent application for Medicinal Aluminum Bottle Processing and Spraying Equipment. Wang Dapeng, Zhang Li and Hu Mingli developed the invention. The patent application number is CN202511246719 20250902. The patent publication number is CN12090..

1 to 100 of 1379 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles